Description

Overview

PT-141 10mg is a high-purity research peptide frequently referenced in scientific and preclinical literature for the study of melanocortin receptor activity, neuropeptide signaling, and receptor-mediated pathways within controlled laboratory environments. Supplied exclusively for research use, it supports structured experimental workflows focused on peptide characterization, assay development, and reproducibility across laboratory investigations. In non-clinical research settings, PT-141 is commonly examined for its interaction with melanocortin receptors and its influence on downstream signaling mechanisms. Researchers may explore its role in receptor binding affinity, signal transduction pathways, and neurochemical responses across a range of experimental models. In vitro studies often include stability profiling, receptor interaction analysis, and comparative evaluations conducted under tightly controlled laboratory conditions. All information regarding this peptide is strictly limited to laboratory-based research. No claims are made regarding therapeutic applications, clinical efficacy, physiological outcomes, or suitability for human or veterinary use.

Key Features

Research-grade synthetic peptide (melanocortin receptor agonist) High-purity material suitable for analytical applications Lyophilized powder for stability and precise handling Widely referenced in receptor signaling and neuropeptide research Verified batch consistency through analytical testing methods

Biochemical Characteristics

PT-141 10mg is a research-grade synthetic peptide extensively referenced in scientific literature for its interaction with melanocortin receptors and its role in neuropeptide signaling pathways within controlled laboratory environments. All characterization of this peptide is conducted strictly through physicochemical analysis and standardized research methodologies. Biochemical evaluation of PT-141 typically includes verification of peptide identity, purity assessment using advanced chromatographic techniques, and stability testing under controlled laboratory conditions. In preclinical research settings, experimental models may investigate its receptor binding properties, signal transduction activity, and peptide stability across various experimental systems. Additional studies often examine solution stability, structural integrity, and consistency across in vitro assays to support reliable and reproducible experimental outcomes. All documentation and evaluation of this peptide remain confined to investigational, non-clinical laboratory research.

Molecular Class: Synthetic peptide (melanocortin receptor agonist)

Compound Name: Bremelanotide (PT-141)

Purity: Research-grade, high-purity material

Material State: Lyophilized powder

Quantity: 10mg per vial

Intended Use: Laboratory research only

Research Applications

Within scientific and preclinical literature, PT-141 10mg is referenced as a research peptide evaluated exclusively in controlled, non-clinical laboratory environments. Its use is limited to analytical investigation, receptor interaction studies, and neuropeptide-related biochemical research conducted under structured experimental protocols.

Documented laboratory research contexts may include:

• Melanocortin receptor studies examining PT-141 interaction with receptor subtypes, binding affinity, and receptor-mediated signaling pathways within controlled experimental models
• Neuropeptide signaling research focused on downstream pathways, intracellular signaling mechanisms, and receptor activation processes under standardized laboratory conditions
• In vitro cellular response modeling within systems designed to observe receptor activity, signal transduction, and peptide-mediated interactions across varying laboratory stimuli
• Peptide stability and integrity testing including evaluation under controlled storage conditions, reconstitution protocols, and experimental environments
• Comparative peptide research exploring structural and functional relationships between PT-141 and other melanocortin analogs
• Analytical benchmarking procedures utilizing validated reference standards, chromatographic verification, and laboratory quality control systems

All referenced applications remain strictly confined to laboratory-based investigation and non-clinical experimental use.

Pathway / Mechanistic Context

In experimental and preclinical research literature, PT-141 10mg is referenced in relation to melanocortin receptor pathways, neuropeptide signaling networks, and receptor-mediated biochemical interactions examined at the molecular level. These investigations are conducted strictly within controlled laboratory environments. Scientific discussion often highlights PT-141 within models of melanocortin system activation and receptor-specific signaling mechanisms. Mechanistic evaluation may include observation of receptor binding interactions, activation of intracellular signaling cascades, and downstream effects associated with melanocortin receptor engagement. Researchers may also examine its association with cyclic signaling processes, neuronal communication models, and signal amplification under controlled in vitro conditions. All mechanistic interpretations remain observational and exploratory in nature and are confined exclusively to non-clinical research settings.

Preclinical Research Summary

Preclinical research literature references observational findings related to PT-141 10mg derived from controlled experimental systems designed to evaluate melanocortin receptor interactions, neuropeptide signaling activity, and receptor-mediated processes within non-clinical research frameworks. Exploratory research discussions often involve evaluation within cellular and biochemical models associated with receptor activation, intracellular signaling cascades, and neuropeptide-mediated communication. Additional analyses may include assessment of peptide stability, consistency across experimental replicates, and observation of downstream cellular responses in regulated in vitro systems. All documented observations remain confined to investigational laboratory contexts and are presented solely for exploratory scientific research purposes.

Form & Analytical Testing

PT-141 10mg is supplied as a research-grade synthetic peptide manufactured under controlled conditions to ensure batch-to-batch consistency, verified identity, and high-purity specifications suitable for laboratory analysis. The material is provided in lyophilized powder form for precise handling and reliable experimental integration. Analytical evaluation typically includes confirmation of peptide identity, purity assessment using high-performance liquid chromatography (HPLC), and molecular mass verification via mass spectrometry. Additional testing includes stability assessment under defined storage and handling conditions. All testing and validation procedures are conducted exclusively to support material characterization within non-clinical laboratory environments.

Storage & Handling

Store at low temperature (commonly -20°C) Protect from light and moisture Reconstitute using sterile laboratory-grade solvents Avoid repeated freeze-thaw cycles

Referenced Citations

Hadley, M. E., & Dorr, R. T. (2006). Melanocortin peptide therapeutics: Historical milestones and clinical development. Peptides. King, S. H., et al. (2007). Melanocortin receptor agonists: Discovery and therapeutic potential. Journal of Medicinal Chemistry. Wessells, H., et al. (2000). Melanocortin receptor agonists and their role in physiological signaling pathways. Journal of Urology. Millington, G. W. M. (2007). The role of melanocortin receptors in neuroendocrine and behavioral regulation. Clinical and Experimental Dermatology. Cone, R. D. (2006). Studies on the physiological functions of melanocortin receptors in laboratory models. Nature. Pfaus, J. G., et al. (2004). Central nervous system mechanisms involving melanocortin receptor activation. Journal of Neuroscience. Shadiack, A. M., et al. (2007). Melanocortin receptor peptides: Mechanistic and pharmacological insights. Regulatory Peptides. Hruby, V. J., & Cai, M. (2013). Design and structure-activity relationships of melanocortin receptor ligands. Peptides.

ALL ARTICLES AND PRODUCT INFORMATION PROVIDED ON THIS WEBSITE ARE FOR INFORMATIONAL AND EDUCATIONAL PURPOSES ONLY. FOR RESEARCH USE ONLY (RUO). NOT FOR HUMAN OR VETERINARY USE.

RUO Disclaimer

All products offered on this website, including PT-141 10mg, are intended strictly for in vitro laboratory research purposes only. In vitro research refers to experimental procedures conducted outside of living organisms within controlled laboratory environments. These materials are not classified as drugs, pharmaceuticals, dietary supplements, or medical products. They have not been reviewed, evaluated, or approved by regulatory authorities for the diagnosis, treatment, cure, or prevention of any disease or medical condition. Any use outside structured laboratory research—including administration to humans or animals—is strictly prohibited. For Laboratory Research Use Only (RUO). Not for human use, medical use, diagnostic use, or veterinary use.